Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Yifan Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China. Hauptthemen laut MEDLINE: Purines, Breast Neoplasms, RNA, Small Interfering, Aminopyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors, such as ribociclib (RB), limits breast cancer therapy. Although PEG10 siRNA (siPEG10) can counteract this resistance, achieving targeted, synchronized co-delivery to reshape the immunosuppressive tumor microenvironment (TME) remains a formidable challenge. By loading RB and siPEG10 into PEG-β-CD-modified mesoporous silica nanoparticles (PMSNs) and coating them with breast cancer cell membranes (CM), the nanocomposite RB/siPEG10@PMSNs-CM was synthesized. The nanomaterials were characterized for their size, charge, drug loading, and pH-responsive release. Therapeutic efficacy, immunotherapy-related potentials, and underlying mechanisms were evaluated using in vitro functional assays, an anoikis resistance model, and in vivo breast cancer models. Toxicity was assessed in liver and kidney tissue. The nanodrug RB/siPEG10@PMSNs-CM (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.
- Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, 110004, China.
- Teaching Center for Basic Medical Experiment, China Medical University, NO.77, Puhe Road, Shenyang, Liaoning, 110122, China.
- Medical Oncology Department of Gastrointestinal Tumors, Liaoning Cancer Hospital and Institute, Liaoning Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Hospital of China Medical University, Can…
- Department of Thoracic Surgery, The First Affiliated Hospital of China Medical University, No. 155 Nangjing Street, Shenyang, Liaoning Province, 110001, China.
- School of Veterinary Medicine, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, 225009, China.
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Yu, Y., Liu, L., Cai, Y., Wang, T., Qiu, K., Huang, X., Wang, Y., Shi, M., Ni, M., Han, C., Ji, X., Cao, L., & Liu, X. (2026). Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218737
Vancouver
Yu Y, Liu L, Cai Y, Wang T, Qiu K, Huang X, et al. Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218737
BibTeX
@article{Yu2026,
author = {Yu, Yifan and Liu, Lidan and Cai, Ying and Wang, Tianshu and Qiu, Kun and Huang, Xinyao and Wang, Yiwen and Shi, Mingzhi and Ni, Man and Han, Chao and Ji, Xianglu and Cao, Liu and Liu, Xiangli},
title = {Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218737}
}
EUVIMED